sb 216763 has been researched along with Potassium Deficiency in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allgaier, C; Camins, A; Canudas, AM; Garcia de Arriba, S; Jiménez, A; Jordà, EG; Pallàs, M; Verdaguer, E | 1 |
1 other study(ies) available for sb 216763 and Potassium Deficiency
| Article | Year |
|---|---|
Implication of cyclin-dependent kinase 5 in the neuroprotective properties of lithium.
Topics: Aminophenols; Analysis of Variance; Animals; Animals, Newborn; Apoptosis; Blotting, Western; Caspases; Cell Survival; Cells, Cultured; Cerebellum; Colchicine; Culture Media, Serum-Free; Cyclin-Dependent Kinase 5; Cyclin-Dependent Kinases; DNA-Binding Proteins; Dose-Response Relationship, Drug; Enzyme Inhibitors; Flow Cytometry; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Indoles; Lithium; Maleimides; MEF2 Transcription Factors; Microscopy, Electron, Transmission; Myogenic Regulatory Factors; Neurons; Neuroprotective Agents; Potassium Deficiency; Rats; Rats, Sprague-Dawley; Serine; Threonine; Time Factors; Transcription Factors | 2005 |